Terms: = Breast cancer AND KDM5C, XE169, SMCX, JARID1C, 8242, ENSG00000126012, DXS1272E, MRXSJ, MRXJ, RP11-258C19_2 AND Treatment
49227 results:
1. Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.
Chen L; Yan X; Luo T; Tian T; He P; Zhong X
Cancer Med; 2024 May; 13(10):e7295. PubMed ID: 38785215
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of calcium variations in single cells and the impact of Yoda1 on osteocytes by ICP-OES.
Guo X; Lin CY; Alavi S; You L; Mostaghimi J
Anal Chim Acta; 2023 Nov; 1281():341906. PubMed ID: 38783744
[TBL] [Abstract] [Full Text] [Related]
3. Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.
Lambert V; Kane S; Howidi B; Nguyen BN; Chandiwana D; Wu Y; Edwards M; Samjoo IA
BMC Cancer; 2024 May; 24(1):631. PubMed ID: 38783218
[TBL] [Abstract] [Full Text] [Related]
4. A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells.
Bulanova D; Akimov Y; Senkowski W; Oikkonen J; Gall-Mas L; Timonen S; Elmadani M; Hynninen J; Hautaniemi S; Aittokallio T; Wennerberg K
Sci Adv; 2024 May; 10(21):eadj1564. PubMed ID: 38781347
[TBL] [Abstract] [Full Text] [Related]
5. Reporting on patient's body mass index (BMI) in recent clinical trials for patients with breast cancer: a systematic review.
Van Cauwenberge J; Van Baelen K; Maetens M; Geukens T; Nguyen HL; Nevelsteen I; Smeets A; Deblander A; Neven P; Koolen S; Wildiers H; Punie K; Desmedt C
Breast Cancer Res; 2024 May; 26(1):81. PubMed ID: 38778365
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer.
Giannubilo I; Battistuzzi L; Blondeaux E; Ruelle T; Poggio FB; Buzzatti G; D'Alonzo A; Della Rovere F; Latocca MM; Molinelli C; Razeti MG; Nardin S; Arecco L; Perachino M; Favero D; Borea R; Pronzato P; Del Mastro L; Bighin C
BMC Palliat Care; 2024 May; 23(1):129. PubMed ID: 38778303
[TBL] [Abstract] [Full Text] [Related]
7. Drug screening on digital microfluidics for cancer precision medicine.
Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
[TBL] [Abstract] [Full Text] [Related]
8. [Adequacy of provision of procedures for early detection of breast cancer in the Brazilian Unified National Health System: a cross-sectional study conducted in Brazil and its regions, 2019].
Dias MBK; Assis M; Santos ROMD; Ribeiro CM; Migowski A; Tomazelli JG
Cad Saude Publica; 2024; 40(5):e00139723. PubMed ID: 38775611
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of oyster mushroom (
Jayaprakash B; Suresh AR; Thiruvengadam R; Alharbi NS; Kadaikunnan S; Sankaran S; Thiruvengadam M; Senthil R; Venkidasamy B
Int J Med Sci; 2024; 21(6):1016-1026. PubMed ID: 38774755
[No Abstract] [Full Text] [Related]
10. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
Qiu R; Fu J
Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
[TBL] [Abstract] [Full Text] [Related]
11. Infrared laser moxibustion for cancer-related fatigue in breast cancer survivors: a randomized controlled trial.
Mao H; Jin M; Xie L; Mao N; Shen X; Chen J; Chen X; Mao JJ; Shen X
Breast Cancer Res; 2024 May; 26(1):80. PubMed ID: 38773552
[TBL] [Abstract] [Full Text] [Related]
12. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
[TBL] [Abstract] [Full Text] [Related]
13. An assessment of the direct and indirect costs of breast cancer treatment in leading cancer hospitals in Ghana.
Okyere Asante PG; Owusu AY; Oppong JR; Amegah KE; Nketiah-Amponsah E
PLoS One; 2024; 19(5):e0301378. PubMed ID: 38771827
[TBL] [Abstract] [Full Text] [Related]
14. Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China.
Jiang H; Zhong J; Wang J; Song G; Di L; Shao B; Zhang R; Liu Y; Zhu A; Wang N; Li H
Cancer Med; 2024 May; 13(10):e7249. PubMed ID: 38770648
[TBL] [Abstract] [Full Text] [Related]
15. Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung cancer Receiving Radiotherapy: A Population-Based Study.
Li P; Luo J; Zheng Z; Meng L; Zhang A; Cao W; Gong X
Cancer Control; 2024; 31():10732748241255212. PubMed ID: 38769789
[TBL] [Abstract] [Full Text] [Related]
16. Autologous fat transplantation prior to permanent expander implant breast reconstruction enhances the outcome after two years: a randomized controlled trial.
Lindegren A; Schultz I; Edsander-Nord Å; Yan J; Wickman M
J Plast Surg Hand Surg; 2024 May; 59():65-71. PubMed ID: 38769740
[TBL] [Abstract] [Full Text] [Related]
17. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Li CY; Wang W; Leung CH; Yang GJ; Chen J
Mol Cancer; 2024 May; 23(1):109. PubMed ID: 38769556
[TBL] [Abstract] [Full Text] [Related]
18. Proteomic characterization and cytotoxic potential of proteins from Cuscuta (Cuscuta epithymum (L.) crude herbal product against MCF-7 human breast cancer cell line.
Akhtar U; Khurshid Y; El-Aarag B; Syed B; Khan IA; Parang K; Ahmed A
BMC Complement Med Ther; 2024 May; 24(1):195. PubMed ID: 38769554
[TBL] [Abstract] [Full Text] [Related]
19. Dermaseptin B2 bioactive gene's potential for anticancer and anti-proliferative effect is linked to the regulation of the BAX/BBC3/AKT pathway.
Nasirabadi FK; Doosti A
Med Oncol; 2024 May; 41(6):162. PubMed ID: 38767753
[TBL] [Abstract] [Full Text] [Related]
20. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
Qi G; Zhang X; Gai X; Yan X
PeerJ; 2024; 12():e17377. PubMed ID: 38766488
[TBL] [Abstract] [Full Text] [Related]
[Next]
